Title:
TELOMERASE INHIBITOR
Document Type and Number:
Japanese Patent JP2002047179
Kind Code:
A
Abstract:
To provide a telomerase inhibitor and an antitumor drug containing a substance having telomerase inhibiting action as active component.
The telomerase inhibitor contains thielavin B expressed by general formula (I), its physiologically permissible salt, its hydrate or its solvate as an active component.
More Like This:
Inventors:
KIMURA JUNKO
FURUI MEGUMI
KANDA MINA
SUGIYAMA MASATO
FURUI MEGUMI
KANDA MINA
SUGIYAMA MASATO
Application Number:
JP2000229208A
Publication Date:
February 12, 2002
Filing Date:
July 28, 2000
Export Citation:
Assignee:
MITSUBISHI TOKYO PHARM INC
International Classes:
C12N9/99; A61K31/235; A61K36/06; A61P35/00; A61P43/00; C07C69/92; C12N1/14; C12P7/62; C12R1/645; (IPC1-7): A61K31/235; A61K35/84; A61P35/00; A61P43/00; C07C69/92; C12N1/14; C12N9/99; C12P7/62
Attorney, Agent or Firm:
Tsutomu Toyama (2 outside)
Previous Patent: TYPE I MATRIX METALLOPROTEASE PRODUCTION INHIBITOR
Next Patent: CYCLOOXYGENASE INHIBITOR AND FOOD AND DRINK CONTAINING THE SAME
Next Patent: CYCLOOXYGENASE INHIBITOR AND FOOD AND DRINK CONTAINING THE SAME